TW202228655A - 控制釋放填充組合物及含彼之膠囊 - Google Patents

控制釋放填充組合物及含彼之膠囊 Download PDF

Info

Publication number
TW202228655A
TW202228655A TW110138319A TW110138319A TW202228655A TW 202228655 A TW202228655 A TW 202228655A TW 110138319 A TW110138319 A TW 110138319A TW 110138319 A TW110138319 A TW 110138319A TW 202228655 A TW202228655 A TW 202228655A
Authority
TW
Taiwan
Prior art keywords
capsule
controlled release
composition
polyoxyethylene
daltons
Prior art date
Application number
TW110138319A
Other languages
English (en)
Chinese (zh)
Inventor
竒 方
卡魯納卡 舒庫魯
Original Assignee
美商Ｒ Ｐ 先靈爾科技公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商Ｒ Ｐ 先靈爾科技公司 filed Critical 美商Ｒ Ｐ 先靈爾科技公司
Publication of TW202228655A publication Critical patent/TW202228655A/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW110138319A 2020-10-16 2021-10-15 控制釋放填充組合物及含彼之膠囊 TW202228655A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063092679P 2020-10-16 2020-10-16
US63/092,679 2020-10-16

Publications (1)

Publication Number Publication Date
TW202228655A true TW202228655A (zh) 2022-08-01

Family

ID=81209315

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110138319A TW202228655A (zh) 2020-10-16 2021-10-15 控制釋放填充組合物及含彼之膠囊

Country Status (14)

Country Link
US (1) US20230372252A1 (enExample)
EP (1) EP4228608A4 (enExample)
JP (1) JP2023545494A (enExample)
KR (1) KR20230088730A (enExample)
CN (1) CN116367864A (enExample)
AR (1) AR123800A1 (enExample)
AU (2) AU2021360905B2 (enExample)
CA (1) CA3195386A1 (enExample)
CO (1) CO2023005368A2 (enExample)
IL (1) IL301692A (enExample)
MX (1) MX2023004441A (enExample)
NZ (1) NZ799086A (enExample)
TW (1) TW202228655A (enExample)
WO (1) WO2022081848A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240099982A1 (en) * 2022-09-27 2024-03-28 Gaia Herbs Cellulose derivative free capsule for herbal extracts

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2627292C (en) * 2005-10-26 2012-04-17 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
US10960077B2 (en) * 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
PE20141171A1 (es) * 2011-10-06 2014-09-21 Gruenenthal Chemie Forma de dosificacion farmaceutica oral resistente a alteracion comprendiendo agonista opioide y antagonista opioide
US20150366814A1 (en) * 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients
WO2016140933A2 (en) * 2015-03-02 2016-09-09 Bionpharma Healthcare Llc Immediate release soluble ibuprofen compositions
EP3285746A1 (en) * 2015-04-24 2018-02-28 Grünenthal GmbH Tamper-resistant fixed dose combination providing fast release of two drugs from particles and a powder
WO2016170097A1 (en) * 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
US9943513B1 (en) * 2015-10-07 2018-04-17 Banner Life Sciences Llc Opioid abuse deterrent dosage forms
EP3856160A4 (en) * 2018-09-25 2022-07-06 SpecGx LLC ABUSE-PROOF IMMEDIATE RELEASE CAPSULE DOSAGE FORMS

Also Published As

Publication number Publication date
AU2026201700A1 (en) 2026-03-26
EP4228608A1 (en) 2023-08-23
AU2021360905B2 (en) 2026-01-08
AU2021360905A1 (en) 2023-06-01
KR20230088730A (ko) 2023-06-20
JP2023545494A (ja) 2023-10-30
NZ799086A (en) 2026-02-27
MX2023004441A (es) 2023-05-08
AR123800A1 (es) 2023-01-11
WO2022081848A1 (en) 2022-04-21
CO2023005368A2 (es) 2023-05-19
CN116367864A (zh) 2023-06-30
CA3195386A1 (en) 2022-04-21
AU2021360905A9 (en) 2024-10-10
IL301692A (en) 2023-05-01
EP4228608A4 (en) 2024-10-02
US20230372252A1 (en) 2023-11-23

Similar Documents

Publication Publication Date Title
US12133922B2 (en) Abuse resistant capsule
AU2026201700A1 (en) Controlled release fill compositions and capsules containing same
US20230390210A1 (en) Modified release softgel capsules
HK40090240A (zh) 控释填料组合物和含有该组合物的胶囊
HK40049427A (en) Abuse resistant capsule
HK40004515A (en) Abuse resistant capsule
HK40004515B (en) Abuse resistant capsule
HK1234661B (zh) 用於干扰易於滥用的药物的提取或转化的方法和组合物